Graham D. Reeve - 28 Feb 2022 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: COO
Signature: /s/ Graham D Reeve
Issuer symbol: USPH
Transactions as of: 28 Feb 2022
Net transactions value: -$192,208
Form type: 4
Filing time: 02 Mar 2022, 10:22:46 UTC
Previous filing: 07 Dec 2021
Next filing: 15 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common StockCommon Stock	Sale	$192,208	-2,118	-22%	$90.75	7,639	28 Feb 2022	Reeve Trust	F1
holding	USPH	Common Stock						10,305	28 Feb 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.68 - $91.11, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 10,305 shares which restrictions lapse as to 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July1 and October 1, 2024 and January 1, 2025; if he is employed by the Company on those dates.

Content

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.68 - $91.11, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Includes 10,305 shares which restrictions lapse as to 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July1 and October 1, 2024 and January 1, 2025; if he is employed by the Company on those dates.